
Mesa Laboratories Inc
MLABMesa Laboratories Inc (MLAB) is a global provider of specialized analytical and monitoring instrumentation, primarily serving the healthcare, pharmaceutical, and biotechnology industries. The company develops and manufactures products for sterilization validation, environmental monitoring, and other quality assurance processes, focusing on ensuring safety and compliance in critical environments.
Dividend History
Investors can expect a dividend payout of $0.16 per share, scheduled to be distributed in 59 days on September 15, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 15, 2026 | $0.16 | 2026-08-31 | 2026-08-31 |
| June 15, 2026 | $0.16 | 2026-05-29 | 2026-05-29 |
| March 16, 2026 | $0.16 | 2026-02-27 | 2026-02-28 |
| December 15, 2025 | $0.16 | 2025-11-28 | 2025-11-28 |
| September 15, 2025 | $0.16 | 2025-08-29 | 2025-08-29 |
Dividends Summary
- Consistent Payer: Mesa Laboratories Inc has rewarded shareholders with 96 dividend payments over the past 23 years.
- Total Returned Value: Investors who held MLAB shares during this period received a total of $12.82 per share in dividend income.
- Latest Payout: The most recent dividend of $0.16/share was paid 33 days ago, on June 15, 2026.
- Yield & Schedule: MLAB currently pays dividends quarterly with an annual yield of 0.65%.
- Dividend Growth: Since 2003, the dividend payout has grown by 220.0%, from $0.05 to $0.16.
- Dividend Reliability: MLAB has maintained or increased its dividend for 79 consecutive payments.
Company News
Mesa Laboratories stock plummeted 19.5% on May 27, 2026, after reporting Q4 fiscal 2026 results. While the company beat expectations on adjusted operating income per share ($3.30 vs. $1.54 estimate), sales of $63.72 million fell short of Wall Street expectations by approximately $1.48 million. CEO Siddhartha Kadia is conducting an internal review...
Mesa Laboratories announced a quarterly dividend of $0.16 per share, payable on September 15, 2025, to shareholders of record as of August 29, 2025.
Mesa Laboratories, Inc. (MLAB) announced a regular quarterly dividend of $0.16 per share, payable on June 16, 2025. The company is a global leader in life science tools and quality control solutions for the pharmaceutical, healthcare, and medical device industries.
Mesa Laboratories, Inc. reported its second quarter fiscal year 2025 results, with revenues increasing 8.8% year-over-year. The company's Biopharmaceutical Development and Calibration Solutions divisions saw strong growth, while the Clinical Genomics division faced headwinds in China and North America.
Mesa Laboratories, Inc. (NASDAQ:MLAB) announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock, payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.

